PAPER Pandey RD, Gupta PP, Jha D, Kumar S
SEARCH RESULTS
331209 RESULTS
PAPER Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
Health Technol Assess. 2013 Feb;17(7):1-166. PubMed: 23438937PAPER Li X, Li TQ, Andreasen N, Wiberg MK, Westman E, Wahlund LO
Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD.
Sci Rep. 2013;3:1339. PubMed: 23439248PAPER Chen P, Wang RR, Ma XJ, Liu Q, Ni JZ
Different Forms of Selenoprotein M Differentially Affect Aβ Aggregation and ROS Generation.
Int J Mol Sci. 2013;14(3):4385-99. PubMed: 23439548PAPER Bai F, Xu Y, Chen J, Liu Q, Gu J, Wang X, Ma J, Li H, Onuchic JN, Jiang H
Free energy landscape for the binding process of Huperzine A to acetylcholinesterase.
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4273-8. PubMed: 23440190PAPER Malm T, Magga J, Koistinaho J
Animal Models of Alzheimer's Disease: Utilization of Transgenic Alzheimer's Disease Models in Studies of Amyloid Beta Clearance.
Curr Transl Geriatr Exp Gerontol Rep. 2012 Mar;1(1):11-20. PubMed: 23440676PAPER Attanasio F, Convertino M, Magno A, Caflisch A, Corazza A, Haridas H, Esposito G, Cataldo S, Pignataro B, Milardi D, Rizzarelli E
Carnosine inhibits Aβ(42) aggregation by perturbing the H-bond network in and around the central hydrophobic cluster.
Chembiochem. 2013 Mar 18;14(5):583-92. PubMed: 23440928PAPER Chen N, Yang M, Guo J, Zhou M, Zhu C, He L
Cerebrolysin for vascular dementia.
Cochrane Database Syst Rev. 2013;1:CD008900. PubMed: 23440834PAPER Capurro V, Busquet P, Lopes JP, Bertorelli R, Tarozzo G, Bolognesi ML, Piomelli D, Reggiani A, Cavalli A
Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease.
PLoS One. 2013;8(2):e56870. PubMed: 23441223PAPER Zhang B, Tian M, Zheng H, Zhen Y, Yue Y, Li T, Li S, Marcantonio ER, Xie Z
Effects of Anesthetic Isoflurane and Desflurane on Human Cerebrospinal Fluid Aβ and Tau Level.
Anesthesiology. 2013 Feb 22; PubMed: 23438677PAPER Brinton RD
Neurosteroids as regenerative agents in the brain: therapeutic implications.
Nat Rev Endocrinol. 2013 Feb 26; PubMed: 23438839PAPER Irwin DJ, Trojanowski JQ, Grossman M
Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease.
Front Aging Neurosci. 2013;5:6. PubMed: 23440936Robert McArthur on New Frontier: Developing Outcome Measures for Pre-dementia Trials
COMMENT Neuropsychiatric drug discovery and development are undergoing a severe crisis, as many high-profile potential drugs with novel mechanisms of action fail to show clinical efficacy at Phase 3. These failures are prompting large pharmaceutical companies to
PAPER McArthur R
Many are called, yet few are chosen. Are neuropsychiatric clinical trials letting us down?
Drug Discov Today. 2011 Mar;16(5-6):173-5. PubMed: 21163366Nandini Raghavan
Johnson & JohnsonNew York, United States
Current Filters
No filters selected